CAS: 442908-10-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Vipadenant REF: IN-DA0039VLCAS: 442908-10-3 | 98% | A consultar | Lun 21 Abr 25 |
 | 3-(4-Amino-3-Methylbenzyl)-7-(Furan-2-Yl)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-5-Amine REF: 54-OR1023107CAS: 442908-10-3 | 98% | 490,00 €~2.005,00 € | Mar 22 Abr 25 |
| Vipadenant REF: 54-BUP07740CAS: 442908-10-3 | 98% | 326,00 €~1.531,00 € | Mar 22 Abr 25 |
 | Vipadenant REF: TM-T2373CAS: 442908-10-3 | 97.25% - 97.36% | 40,00 €~1.130,00 € | Lun 28 Abr 25 |
 | Vipadenant REF: 3D-SSA90810CAS: 442908-10-3 | Min. 95% | - - - | Producto descatalogado |
Ref: IN-DA0039VL
| 2mg | 50,00 € | ||
| 5mg | 77,00 € | ||
| 10mg | 127,00 € | ||
| 25mg | 200,00 € | ||
| 100mg | 693,00 € | ||
| 250mg | A consultar |
Entrega estimada en Estados Unidos, el Lunes 21 de Abril de 2025
![3-(4-Amino-3-Methylbenzyl)-7-(Furan-2-Yl)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-5-Amine](https://static.cymitquimica.com/products/54/thumb/OR1023107.jpg)
3-(4-Amino-3-Methylbenzyl)-7-(Furan-2-Yl)-3H-[1,2,3]Triazolo[4,5-D]Pyrimidin-5-Amine
CAS:442908-10-3
Pureza:
98%
Peso molecular:
321.34g/mol
Ref: 54-OR1023107
| 1g | 2.005,00 € | ||
| 100mg | 490,00 € | ||
| 250mg | 819,00 € |
Entrega estimada en Estados Unidos, el Martes 22 de Abril de 2025
Ref: 54-BUP07740
| 25mg | 326,00 € | ||
| 50mg | 523,00 € | ||
| 100mg | 779,00 € | ||
| 500mg | 1.531,00 € |
Entrega estimada en Estados Unidos, el Martes 22 de Abril de 2025
Vipadenant
CAS:442908-10-3
Vipadenant (CEB-4520)(BIIB-014) is an adenosine A2a antagonist with Ki of 1.3 nM; less potent for …
Fórmula:
C16H15N7O
Pureza:
97.25% - 97.36%
Forma y color:
Solid
Peso molecular:
321.34
Ref: TM-T2373
| 1mg | 40,00 € | ||
| 2mg | 52,00 € | ||
| 5mg | 87,00 € | ||
| 10mg | 119,00 € | ||
| 25mg | 210,00 € | ||
| 50mg | 350,00 € | ||
| 100mg | 522,00 € | ||
| 500mg | 1.130,00 € | ||
| 1mL*10mM (DMSO) | 359,00 € |
Entrega estimada en Estados Unidos, el Lunes 28 de Abril de 2025
Vipadenant
CAS:442908-10-3
Vipadenant is a new drug that has been developed for the treatment of cancer. It …
Fórmula:
C16H15N7O
Pureza:
Min. 95%
Peso molecular:
321.34 g/mol
Ref: 3D-SSA90810
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información | |
| 100mg | Descatalogado | Solicitar información |
